Overactive Bladder clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinary incontinence and either normal or mildly impaired cognitive function at baseline.
San Francisco, California and other locations
Our lead scientists for Overactive Bladder research studies include Alison Huang, MD, MAS, MPhil.